Prospect Enhanced Yield Fund Announces Dividend Increase to 11.5% Annualized RateNEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Prospect Enhanced Yield Fund (“PENF” or the “Fund”) announced today that the Fund’s Board of Directors has declared a $0.04775 increase in the monthly cash shareholder distributions for July, August, and September 2026. These distributions represent the 10th, 11th, and 12th monthly distributions paid by the Fund.
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in SchizophreniaThe trial, designed and sized to support registration, met its primary endpoint, with the 210/3 mg BID dose demonstrating a statistically significant improvement in PANSS total score compared to placebo at Week 5 with an effect size of 0.37 (LS mean difference vs PBO -4.5, p=0.015)
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026LONDON and NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced its participation in the BTIG Biotechnology Conference 2026 taking place virtually on July 28-29, 2026.
Baker Hughes Secures Major LNG Technology Order for Venture Global’s CP2 LNG ExpansionHOUSTON and LONDON, July 27, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (
NASDAQ: BKR), an energy technology company, announced Monday a major order, booked in the second quarter, from Venture Global LNG to provide a comprehensive liquefaction solution for its CP2 LNG expansion project in Louisiana.
Legence Sets Second Quarter 2026 Earnings Release Date and Webcast ScheduleSAN JOSE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it will release results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026, prior to the market open.
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis StudyBEIJING, July 27, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that its novel TYK2 (Tyrosine Kinase 2) inhibitor fadeucravacitinib (ICP-488) met the primary endpoint in the registrational Phase III clinical study in patients with moderate-to-severe plaque psoriasis.
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.Transaction expected to deepen Vireo's positions in Nevada and Florida, complement its growing Illinois platform, and further strengthen one of the industry's broadest multi-state cannabis operating platforms
CorVel Corporation to Host Live Earnings Release WebcastFORT WORTH, Texas, July 27, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (
NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Wednesday, August 5, 2026, at 11:30 AM Eastern Time.
Allot to Release Second Quarter 2026 Results and Host Conference Call on August 12, 2026Hod Hasharon, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and network intelligence solutions for communications service providers and enterprises, announced today that it will host a conference call to discuss its second quarter 2026 results on Wednesday, August 12, 2026 at 8:30AM ET (1:30PM UK, 3:30PM Israel).
Artel Announces New Carrier-Class PTP Switch Built for the Demands of Modern BroadcastThe new Quarra PTP-10GSE12SFP 10 Gbps PTP Ethernet Switch Delivers Nanosecond-Accurate Timing, 20 Ports of Flexible Connectivity, and Full SMPTE 2110 Interoperability for Pro-AV, Media Broadcast, and Industrial Networks
Legend Biotech Announces CEO TransitionBRIDGEWATER, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (
NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced that Ying Huang, Ph.D., has stepped down as Chief Executive Officer and as a member of the Board of Directors, effective as of July 24, 2026. Dr. Huang will remain as an advisor through August to support a smooth transition.
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics CompanyBERKELEY, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of a non-binding term sheet with a privately held, commercial-stage health diagnostics and toxicology testing company (the "Dx Company"). Following the contemplated transaction, the combined company is expected to operate as a public diagnostics company with national CLIA-certified laboratories, recurring revenues from a diversified base of providers serving addiction treatment, pain management, and behavioral health. The Dx Company’s 2025 Net Revenues are estimated, based on unaudited management information, to be approximately $111 million.
Rocket Lab Awarded Record $266M Missile Defense Contract with U.S. Space Force for Suborbital LaunchesLONG BEACH, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems today announced it has been awarded its largest launch contract to date, a $266 million multi-launch contract with the U.S. Space Force. This landmark contract further solidifies Rocket Lab’s position as a leader in launch and critical mission enabler for programs with significant national importance.
KBR Selected by Power2X as Project Management Consultant for its eFuels Project in RotterdamHOUSTON, July 27, 2026 (GLOBE NEWSWIRE) -- KBR (
NYSE: KBR) announced it has been awarded the Project Management Consultant (PMC) contract by Power2X for its eFuels project in Rotterdam.
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAMMaranello (Italy), July 27, 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on April 10, 2026, as the second tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “Second Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) as follows:
Transaction in Own SharesTransaction in Own Shares
VEON's Banglalink Demonstrates the Power of Digital Ecosystems with Record FIFA World Cup 2026 EngagementBanglalink's digital entertainment platform recorded 2 billion live watch minutes and 20 million monthly active users during the 39-day tournament, as premium sports streaming reaches new heights in Bangladesh
Multiverse Computing Announces Series C Fundraising Targeting up to $570M (€500M) to Power Efficient AI from Edge to CloudForgepoint Capital International, BNPP Solar Impulse Venture Fund, and Bullhound Capital lead the round as a consortium of global technology firms, sovereign funds, and strategic investors converge on efficient AI
LEADING EDGE MATERIALS WELCOMES SWEDISH MINERAL STRATEGY AND POTENTIAL MEASURES TO ACCELERATE STRATEGIC PROJECTSLEADING EDGE MATERIALS WELCOMES SWEDISH MINERAL STRATEGY AND POTENTIAL MEASURES TO ACCELERATE STRATEGIC PROJECTS
Lucidya expands global leadership team, recruiting senior talent from ServiceNow, Qualtrics, Brandwatch, Talkdesk, and GenesysRIYADH, Saudi Arabia, July 27, 2026 (GLOBE NEWSWIRE) -- Following its record-breaking Series B in 2025, the largest AI funding round in MENA at the time, Lucidya has expanded its global leadership team with the appointment of William O’Neill, former ServiceNow and Qualtrics executive, as Chief Revenue Officer; Steve Adkins, former Brandwatch executive, as Vice President of Sales; and Anand Shrivastava, former Talkdesk and Genesys product leader, as Vice President of Product.
Silvaco to Accelerate Physics-Based Digital Twins for Semiconductor Design and Manufacturing Using NVIDIA AI and Accelerated ComputingSilvaco is integrating NVIDIA accelerated computing and AI with its physics-based simulation portfolio to advance digital twins for semiconductor design and manufacturing
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, today announced that its Chairman and Chief Executive Officer, Dr. Dajun Yang, has been named to The Medicine Maker Power List 2026, ranking No. 3 among the Top 10 in the Small Molecules category. Published annually, the Power List recognizes global leaders across small molecules, biopharma and advanced therapies. Nominated by industry peers worldwide and selected by a panel of expert judges, the Power List celebrates individuals whose work continues to advance drug discovery, manufacturing innovation and patient access to innovative medicines. The 2026 edition honors 60 distinguished leaders from across the global pharmaceutical industry.
Baker Hughes Declares Quarterly DividendHOUSTON and LONDON, July 26, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (
NASDAQ: BKR) announced today that the Baker Hughes Board of Directors declared a quarterly cash dividend of $0.23 per share of Class A common stock payable on Aug. 17, 2026, to holders of record on Aug. 7, 2026.
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesALISO VIEJO, Calif., July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (
NASDAQ: RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286 shares of RxSight’s common stock and inducement restricted stock units (RSUs) covering a total of 2,312,138 shares of RxSight’s common stock to Aziz Mottiwala, RxSight’s new President and Chief Executive Officer in connection with his commencement of employment with RxSight.
Storj Announces Voluntary Financial Restructuring to Resolve Legacy Liabilities and Position the Business for GrowthStorj operations, service, and the network continue as normal; parent continues its support; process designed to align ownership among management, the decentralized community, Token holders, and investors
Everbright Digital Holding Limited Announces Pricing of $8.07 Million Public OfferingHong Kong, July 26, 2026 (GLOBE NEWSWIRE) -- Everbright Digital Holding Limited (
NASDAQ: EDHL) (“Company” or “Everbright”), an integrated marketing solutions provider headquartered in Hong Kong, today announced the pricing of its public offering (“Offering”) for the purchase and sale of 4,293,000 of the Company's ordinary shares, par value US$0.00064 per share (the "Ordinary Shares"). Each Ordinary Share will be sold at an offering price of $1.88 per share. The gross proceeds to the Company from the Offering are expected to be approximately $8.07 million, before deducting placement agent fees and other Offering expenses payable by the Company
GSJJ Launches Long-Lasting Custom Neon Signs for Graduation CelebrationsLOS ANGELES, July 25, 2026 (GLOBE NEWSWIRE) -- GSJJ, a manufacturer of custom promotional gifts, has announced the launch of a line of long-lasting custom neon signs designed specifically for "Class of 2026" graduation ceremonies and parties. These signs not only create a personalized celebratory atmosphere but also help avoid the waste associated with single-use decorations.
Donors Rock! KSHE Summer Blood Drive Wrap-UpSt. Louis classic rock fans provide 1896 donations at critical time of year
CertiK Intel3D: H1 2026 Wrench Attacks Report Reveals 33% Surge in Physical Crypto Crime, Estimated Losses Top $124 MillionNEW YORK, July 25, 2026 (GLOBE NEWSWIRE) -- CertiK recently released its Intel3D: H1 2026 Wrench Attacks Report, revealing that physical coercion against crypto holders intensified in the first half of 2026. CertiK recorded 52 verified wrench attacks globally, up from 39 in H1 2025, with recorded financial exposure reaching an estimated $124.1 million. The findings confirm that wrench attacks are a structural threat facing crypto holders, founders, and institutions worldwide.
Urbanica Furniture Simplifies Office Setup with Customizable Workspace BundlesCurated desk and ergonomic chair combinations, along with flexible configuration options, help customers create coordinated workspaces based on available space, comfort needs, and daily routines
EQUIPMENTSHARE.COM, INC. (EQPT) INVESTOR ALERT Investors With Large Losses in EquipmentShare.com, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) EquipmentShare.com, Inc. (“EquipmentShare” or the “Company”) (
NASDAQ: EQPT) Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s January 2026, initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 23, 2026 and June 23, 2026, inclusive (the “Class Period”).
SiriusPoint Announces Date for Second Quarter 2026 Earnings ReleaseHAMILTON, Bermuda, July 24, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (
NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its second quarter 2026 financial results after the market close on Wednesday, July 29, 2026. The Company will also hold a conference call, including a question-and-answer session, to discuss its financial results at 10:30 am (Eastern Time) on Thursday, July 30, 2026.
UPDATE – SuperCritical Materials Licenses Patented Uranium and Critical Materials Extraction TechnologyLicensed uranium extraction technology positions SuperCritical to help address America's emerging nuclear fuel supply bottleneck as advanced reactor deployments accelerate.
Fairfax Announces Conference CallTORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, July 31, 2026 to discuss its 2026 second quarter results, which will be announced after the close of markets on Thursday, July 30, 2026 and will be available at that time on its website at www.fairfax.ca. The call, consisting of a presentation by the company followed by a question period, may be accessed at 1 (800) 369-2143 (Canada and U.S.) or 1 (312) 470-0063 (International) with the passcode “FAIRFAX”.
Timbercreek Financial Declares July 2026 DividendTORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) (the “Company” or “Timbercreek Financial”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on August 14, 2026 to holders of Common Shares of record on July 31, 2026.
Flock LPR Helps Locate Stabbing Suspect Across Three States in 24 HoursLa Crosse, WI, July 24, 2026 (GLOBE NEWSWIRE) -- A woman holding her 11-month-old daughter was stabbed multiple times outside her home in La Crosse, Wisconsin. Within 24 hours, the suspect was in custody in Indiana.
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities DeficiencyMdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 65,886 restricted stock units of the company’s common stock to 39 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of July 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Gogo to Report Second Quarter 2026 Financial Results on August 6, 2026BROOMFIELD, Colo., July 24, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (
NASDAQ: GOGO), the leading global provider of broadband connectivity services for the business aviation, military, and government markets, announced today that it will release its second quarter 2026 financial results before the market opens on August 6, 2026. The Company will host a conference call with financial analysts on the same day at 8:30 a.m. (ET).
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (
NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future GrowthZURICH, SWITZERLAND , July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in the design and development of next-generation cancer therapeutics, held an Extraordinary General Meeting (EGM) today. All resolutions proposed by the Board of Directors and previously communicated in the company’s July 2, 2026 shareholder materials were approved by an overwhelming majority of more than 99.94% of the shareholders present or represented at the meeting. In total, 102,102,301 voting shares, corresponding to 72.20% of the total share capital, were represented.
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., July 24, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 12 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).
Flock LPR Helps Atlanta Police Locate Fatal Stabbing Suspect Same DayAtlanta, GA, July 24, 2026 (GLOBE NEWSWIRE) -- A 23-year-old woman was fatally stabbed on the 1700 block of Flagler Avenue NE near the Atlanta Beltline on a Thursday afternoon. Before the day was over, the suspect was in custody.
Innovation Growth Partners Specialty Names David Nikolai President, Programs DivisionAtlanta, GA, July 24, 2026 (GLOBE NEWSWIRE) -- Innovation Growth Partners Specialty (IGP Specialty), one of the largest specialty insurance firms in the United States, and part of the USI Insurance Services family of companies, is pleased to announce that it has named David Nikolai as President, Programs Division, effective immediately.
ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff DeadlineBragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options
VAST Data Expands Collaboration with AMD to Advance AI Infrastructure for the Inference EraVAST AI Operating System and AMD EPYC™ CPUs, AMD Instinct™ GPUs and AMD Pensando™ Pollara 400 AI NICs deliver breakthrough inference performance and efficiency for AI clouds, enterprises and agentic AI workloads
AEROVIRONMENT DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds AeroVironment, Inc. Investors They Have Until July 27th to Contact the Firm Seeking Lead Plaintiff RoleIf you purchased or acquired AeroVironment securities between June 25, 2025 and June 18, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or by telephone at (212) 355-4648.
MICROSOFT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Microsoft Corporation Investors to Contact the Firm Regarding Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Microsoft (MSFT) To Contact Them Directly To Discuss Their Options
CALIX, INC. CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Calix, Inc. (NYSE:CALX) Investors to Contact the Firm Regarding Their Rights Before July 27thBragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Calix (CALX) To Contact Them Directly To Discuss Their Options
Imagine’s Andy House and 7-Eleven’s Terri Micklin to Present at Outlook Leadership 2026MINNEAPOLIS, July 24, 2026 (GLOBE NEWSWIRE) -- Imagine announced today that Andy House, Vice President of Imagine Studio, will join Terri Micklin, Senior Vice President of Store Development, Facilities, and Real Estate at 7-Eleven, for a featured session at Outlook Leadership 2026, one of the convenience industry’s premier executive conferences.
CFP Board Promotes Public Trust With 14 ActionsUpholding Ethical Standards in a Thriving Network of Over 109,000 CFP® Professionals
Hubbell Declares Regular Quarterly DividendShelton, CT, July 24, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Hubbell Incorporated (
NYSE:HUBB) today declared a regular quarterly dividend of $1.42 per share on the Company’s common stock. The dividend will be paid on September 15, 2026 to shareholders of record on August 31, 2026.
